X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs ORCHID PHARMA LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. ORCHID PHARMA LTD WOCKHARDT LTD./
ORCHID PHARMA LTD
 
P/E (TTM) x -11.8 0.2 - View Chart
P/BV x 2.4 0.2 1,163.2% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 WOCKHARDT LTD.   ORCHID PHARMA LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
ORCHID PHARMA LTD
Sep-13
WOCKHARDT LTD./
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,129194 582.0%   
Low Rs62735 1,791.4%   
Sales per share (Unadj.) Rs363.1276.5 131.4%  
Earnings per share (Unadj.) Rs-20.4-79.2 25.8%  
Cash flow per share (Unadj.) Rs-7.0-43.5 16.1%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs301.853.9 559.6%  
Shares outstanding (eoy) m110.5570.45 156.9%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x2.40.4 583.8%   
Avg P/E ratio x-42.9-1.4 2,970.6%  
P/CF ratio (eoy) x-125.9-2.6 4,776.8%  
Price / Book Value ratio x2.92.1 137.0%  
Dividend payout %-48.90-   
Avg Mkt Cap Rs m97,0638,067 1,203.3%   
No. of employees `0006.82.8 241.7%   
Total wages/salary Rs m9,6652,527 382.5%   
Avg. sales/employee Rs Th5,931.86,956.1 85.3%   
Avg. wages/employee Rs Th1,428.1902.5 158.2%   
Avg. net profit/employee Rs Th-334.0-1,993.0 16.8%   
INCOME DATA
Net Sales Rs m40,14619,477 206.1%  
Other income Rs m1,143407 280.6%   
Total revenues Rs m41,28919,884 207.6%   
Gross profit Rs m1281,103 11.6%  
Depreciation Rs m1,4892,519 59.1%   
Interest Rs m2,2535,227 43.1%   
Profit before tax Rs m-2,472-6,236 39.6%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-211-125 168.6%   
Profit after tax Rs m-2,260-5,580 40.5%  
Gross profit margin %0.35.7 5.6%  
Effective tax rate %8.52.0 425.4%   
Net profit margin %-5.6-28.7 19.7%  
BALANCE SHEET DATA
Current assets Rs m46,16011,014 419.1%   
Current liabilities Rs m19,25832,060 60.1%   
Net working cap to sales %67.0-108.1 -62.0%  
Current ratio x2.40.3 697.7%  
Inventory Days Days10195 106.2%  
Debtors Days Days9434 280.3%  
Net fixed assets Rs m40,16529,440 136.4%   
Share capital Rs m553705 78.5%   
"Free" reserves Rs m32,8142,043 1,606.5%   
Net worth Rs m33,3673,800 878.1%   
Long term debt Rs m31,9039,018 353.8%   
Total assets Rs m89,68746,510 192.8%  
Interest coverage x-0.1-0.2 50.3%   
Debt to equity ratio x1.02.4 40.3%  
Sales to assets ratio x0.40.4 106.9%   
Return on assets %0-0.8 1.1%  
Return on equity %-6.8-146.9 4.6%  
Return on capital %-0.3-3.7 9.0%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m9,1217,513 121.4%   
Fx outflow Rs m2,1335,649 37.8%   
Net fx Rs m6,9881,865 374.8%   
CASH FLOW
From Operations Rs m-2,6951,682 -160.2%  
From Investments Rs m-6,863-9,860 69.6%  
From Financial Activity Rs m12,5456,644 188.8%  
Net Cashflow Rs m3,010-1,535 -196.1%  

Share Holding

Indian Promoters % 74.5 32.3 230.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 4.6 50.0%  
FIIs % 7.7 3.3 233.3%  
ADR/GDR % 0.1 4.6 2.2%  
Free float % 15.4 55.3 27.8%  
Shareholders   67,757 84,811 79.9%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   DR. DATSONS LABS  STRIDES SHASUN LTD  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Metal Stocks Drag(09:30 am)

Asian share markets slipped in the opening trade today as investors digested the escalation in trade tensions between the US and China after both countries announced tariffs last week.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jun 18, 2018 11:37 AM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS